Manufacturing Investment Committee Adviser — Utilisation and Replacement Choices

The mandate

A manufacturing investment committee receives replacement proposals whose benefits depend on better utilisation as well as newer equipment. The papers seldom explain whether the existing constraint is machine condition, process imbalance or insufficient saleable demand. An independent adviser will help the committee test those distinctions and compare replacement with refurbishment, selective debottlenecking or a decision to preserve capital.

The nine-month retainer starts on 26 October 2026 and reserves four days each month, including one quarterly investment meeting and planned site evidence work within that capacity. A monthly proposal challenge session and written alternatives note establish the cadence. Urgent questions are acknowledged within one business day, with substantive advice within four business days once the proposal and relevant source evidence are complete.

The standing issue is the financial rationale for an asset decision, not technical approval of the equipment. A higher nameplate capacity has little investment value when another process stage limits saleable output. Conversely, replacement may be justified by reliability, maintenance exposure or product capability even when throughput is unchanged. The adviser asks which benefits are supported, what alternative would address the same constraint and what evidence might reverse management's recommendation.

The retainer gives no line authority over plant or procurement staff and no executive responsibility for capital delivery. Engineering owners substantiate condition and capability; management selects suppliers and implements authorised projects; the committee makes its own decisions. No directorship or fiduciary appointment is included. The adviser must not sign off a technical safety conclusion or assume that broad manufacturing experience provides authority to certify one.

Concurrent advisory work is limited to two other appointments with protected monthly capacity and disclosed interests. Supplier remuneration, relationships with equipment bidders and advice to a competing purchaser require committee-chair review before access to proposal papers. Renewal is considered at month eight and requires written chair recommendation and governing-board approval, with any further term limited to twelve months and a refreshed question set.

What you will own

• Challenge the link between proposed equipment capability and saleable output, asking management to identify the actual limiting process or demand condition before the committee credits an incremental revenue benefit.
• Examine utilisation measures for differences between scheduled time, effective operation and commercially recoverable production, recommending clarification where an average obscures the cause of apparent spare capacity.
• Compare replacement, refurbishment and selective debottlenecking through their financial consequences, requiring management to explain why less capital-intensive alternatives cannot adequately address the stated operating need.
• Probe maintenance and reliability benefits using supplied failure and cost evidence, separating avoided expenditure from uncertain production losses whose recovery depends on an unverified demand assumption.
• Shape downside questions around installation interruption, ramp losses and residual asset value, helping the committee understand what must happen after approval for the claimed return to materialise.
• Recommend post-investment evidence requirements that preserve the original decision assumptions, allowing later reviews to distinguish an inaccurate capital case from a project executed differently by management.
• Advise on decision-record clarity and unresolved specialist findings, ensuring the committee's chosen trade-off remains visible without directing engineering work or authorising supplier commitments on its behalf.

Candidate qualifications

• Extensive manufacturing finance, controlling or senior industrial investment experience should include capital decisions involving operating constraints and asset replacement. Describe a proposal you challenged because the projected utilisation benefit did not follow from the evidence. Explain which alternative was considered and how the authorised decision changed after your financial analysis, rather than simply quoting the calculated investment return.
• Bring applied skill in capital appraisal, cost behaviour and production economics across more than one asset type. Evidence should show that you can distinguish throughput, reliability and capability benefits and test whether they translate into usable cash or contribution. Explain a technically attractive replacement whose financial merits depended on another process or commercial condition outside the investment itself.
• Demonstrate constructive independent committee communication and respect for engineering judgement. The adviser must identify unsupported financial inferences without claiming technical certification. Provide a case where specialist findings remained conditional, how you represented that uncertainty to decision makers and what evidence or decision condition you recommended before further capital could reasonably be committed.
• Establish four-day monthly availability, practical site-review capacity and freedom from supplier-linked incentives. Disclose relevant procurement relationships, financial interests and competing advisory appointments. Your contribution should include disciplined written challenge and follow-up of accepted assumptions while leaving project execution with management, preserving independence even when the preferred proposal has substantial internal sponsorship.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 10 October 2026. Mandate reference CVU-ADV-2026-IND-059.